ETAP-Lab - Preclinical Efficacy CRO

#WorldStrokeDay2024 🧠The human brain is an extraordinary machine. #brainpower Every second, 100 billion neurons fire 5 to 50 messages each, creating intricate neural networks that shape our identity and life history. But when stroke strikes, those connections are interrupted, and the lives of patients & families are changed forever.   👨🔬 Today, more than ever, we're thinking of all stroke patients and their healthcare professionals. This is a source of motivation at #StrokAlliance as we support our customers in their quest for therapeutic solutions.   Prevention starts with early attention to the first signs of stroke. We believe in continuing to communicate and raise #StrokeAwareness , because #timeISbrain ! 👇👇 #PreventStroke Flip through the carousel to know the facts about #RiskFactors like #diabetes and #obesity    🙏World Stroke Organization

🔬It’s #fluorescencefriday ! 🤔How to improve the reliability of preclinical models for the discovery of neuroprotective drugs to treat neurodegenerative diseases? 💡The answer lies in the following images!   In control conditions, a large number of synaptic PSD95 puncta localized in the neurite branching of cortical neurons are observed. After treatment with amyloid-β oligomers (0.5 µM, 72 h), a significant reduction in the number of these puncta was noted.    🧠Synaptic loss is a key factor in cognitive decline in both preclinical and clinical studies and evidence suggests that oligomeric forms of amyloid-β are responsible for this synaptotoxicity.   👨🔬Valentin TALLANDIER, our project leader, explains: “Our data were obtained using a high-content imaging and analysis system. This approach provides a valuable & powerful tool to accelerate drug discovery for Alzheimer’s disease.”   Our in vitro models of Alzheimer’s disease aim to support pharmaceutical and biotech companies in their quest to develop novel therapies that target #SynapticRegeneration.   👋Stay connected to discover more scientific content and follow us on Linkedin   #NeurodegenerativeDiseases #DrugDiscovery #PreclinicalModels #AlzheimersDisease #SynapticLoss #HighContentImaging 📸Original picture © ETAP-Lab 2024. Digitally captured using #OPERETTA CLS by Revvity

🧠We believe our innovative preclinical model will be a solid tool for evaluating the safety and efficacy of future drugs in #StrokeResearch. That's why we were delighted to present our e-poster at the short communication session #WSC2024! By incorporating common comorbidities, we're ensuring our preclinical stroke model is highly translational. Discover the e-poster in details wherever you prefer: ✅At the E-Poster stations until October, 26th, with Annelise Letourneur or Nicolas Violle onsite specially from France to meet you in #abudhabi ☑️At the e-Poster gallery on the Congress virtual platform or in the mobile app 👋Request the PDF poster   Can't wait to see you at World Stroke Organization Congress!

🌍Hope to see you tomorrow in Abu Dhabi at the #WSC2024!   🧠Join Nicolas Violle, and Annelise Letourneur, Neuroscience Study Director to discover our short poster presentation in #StrokeResearch on original preclinical results reproducing translational challenges of #MetabolicDiseases #diabetes and #aging. 👩🔬Reminder: Session Time: 14:00 - 15:30 (0460, ID 1584) - Room: Hall G - Wed, 23.10.2024 - Lecture Time: 14:56 - 15:00   Ask for the PDF poster right here 👉 https://lnkd.in/ei_jj5bD #StrokAlliance

📌We'll be there in #WSC2024 in Abu Dhabi next week! 🌍 Join the leading researchers in stroke research and explore the forefront of stroke and #cerebrovascularDisease topics at World Stroke Congress with World Stroke Organization! 🧠We'll unveil our poster on original preclinical results about in vivo assays on Stroke disease, reproducing translational challenges of #MetabolicDiseases and aging.   📅Join our expert, Annelise Letourneur, Neuroscience Study Director, during her poster presentation: "Translational models of hemorrhagic transformation to evaluate the safety of new therapies in acute stroke: effects of age and hypertension in diabetic mice". 👩🔬Session Time: 14:00 - 15:30 (0460, ID 1584) - Room: Hall G - Wed, 23.10.2024 - Lecture Time: 14:56 - 15:00 More information: https://lnkd.in/ei_jj5bD #WSC2024 #StrokeResearch #StrokAlliance

Better than any certification, customer recognition is our driving force. 📣We're proud to announce our strategic partnership with Kisolite Corp, a leader in innovative #therapeutic solutions. Together, we're advancing in vivo studies for their therapeutic product targeting Inflammatory Bowel Disease (IBD). #IBDResearch   🤝It's important for us to establish a trustful and long-lasting relationship. Beyond expertise, our flexible, human-sized organization provides dedicated support and guides customers every step of the way. 💊   Ready to collaborate on your next drug efficacy study? 👇Contact us today to explore how ETAP-Lab can contribute to your success!    #Pharmaceutical #DrugDiscovery #Innovation #biotech More about the partnership: https://lnkd.in/ei_jj5bD

🫧World Mental Health Day At ETAP-Lab, caring for our employees means investing in the company's success. ☀️ Our recent integration day in Caen (France) and on the Normandy beaches made possible the convivial moments shared between our 3 sites' employees to strengthen bonds, foster cohesion and a positive and caring atmosphere at work.   --- 🫧Journée mondiale de la santé mentale Chez ETAP-Lab, prendre soin de ses collaborateurs, c'est investir dans la réussite de l'entreprise. ☀️ Notre récente journée d’intégration à Caen (France) et sur les plages du débarquement en Normandie en témoigne : des moments conviviaux partagés entre les salariés des 3 sites pour renforcer les liens et favoriser la cohésion et un environnement de travail positif et bienveillant.   #santémentale #teambuilding #bienetreautravail #cohesionéquipe #WorldMentalHealthDay #wellnessAtWork #ETAPLabGroup with SYNCROSOME - Cardiovascular Preclinical expert and #StrokAlliance

We were delighted to take part in the User Meeting Group by #Revvity last week in Rome, Italy. 🔬Valentin TALLANDIER, in vitro project leader, presented our work in progress obtained with high-throughput reader #Operetta, such a great technological tool to work with in our #PreclinicalStudies. Our ongoing work on the automation and quantification of synapses in microfluidic devices is highly promising!!! 👍Our warmest thanks to Revvity for the invitation and for this nice event!   #Neurology #Brain #Microscopy #drugdiscovery

👩🔬Today and tomorrow, there are 2 days left to meet our experts at the NEUROSCIENCE meeting #SFN2024 and to discover our brand new #preclinical results and advances in our two posters presentations! 👉PSTR387.08 and PSTR013.14 🧠 #AlzheimersDisease #neurodegenerativeDisease #neuroInflammation #drugresearch #BrainOnChip NETRI   👉 Visit our website for more information on our #preclinicalmodels https://lnkd.in/e5XcrQ-3   Organized by Society for Neuroscience

🧠 Can't wait to see you tomorrow in #Chicago at the NEUROSCIENCE #SFN24 !! ✅Don't miss Nicolas Violle on October 5, 2024 at 2 p.m. for his presentation "Towards new relevant #neuroinflammation models using oligomers involved in Alzheimer’s disease for target validation and drug testing" (poster number PSTR013.14 ) #preclinicalresults #AlzheimersDisease